The relationship of selective serotonin reuptake inhibitors with parkinson's disease and parkinsonism: Two case reports;Seçici serotonin geri alım inhibitörleri ile parkinson hastalıǧı ve parkinsonizm ilişkisi: İki olgu sunumu

Anadolu Psikiyatri Dergisi

Volumn 12, Issue 4, 2011, Pages 315-317

  Erdoǧan Taycan, Serap ^a   Demir, Süleyman ^a   Çelikel, Feryal ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

Essitalopram; Extrapyramidal system; Parkinsonism; Paroxetine

Indexed keywords

ESCITALOPRAM; PAROXETINE;

ARTICLE; CASE REPORT; CHILDHOOD; FEMALE; HUMAN; PARKINSON DISEASE; PARKINSONISM; PSYCHOSOCIAL WITHDRAWAL;

EID: 81855184471     PISSN: 13026631     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hariri AG, Ceylan ME. Depresyonda ilaç tedavisi: Özgül serotonin geriali{dotless}m engelleyicileri. Duygudurum Dizisi 2003; 7:339-345.
2. Stahl SM. Temel Psikofarmakoloji Nörobilimsel Temeli ve Pratik Uygulamalari{dotless}. B Taneli, Y Taneli (Çev), İstanbul, Yelkovan Yayi{dotless}nci{dotless}li{dotless}k, 2003, s.222-405.
3. Haddad PM, Dursun SM. Neurological complications of psychiatric drugs: clinical features and management. Hum Psychopharmacol Clin Exp 2008; 23:15-26.
4. Nguyen N, Pradel V, Micallef J, Montastruc JL, Blin O. Drug-induced parkinsonism syndromes. Therapie 2004; 59:105-112.
5. Lane RM. SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. J Psychopharmacol 1998; 12:192-214.
6. Arnone D, Hansen L, Kerr JS. Acute dystonic reaction in an elderly patient with mood disorder after titration of paroxetine: possible mechanisms and implications for clinical care. Psychopharmacol 2002; 16:395-397.
7. Ozalp E, Soygur H, Cankurtaran ES, Turhan L, Cekic T, Akarsu ES, et al. Sertraline, escitalopram and tianeptine related abnormal movements but not with bupropion: a case report. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30:1337-1339.
8. Hedenmalm K, Güzey C, Dahl ML, Yue QY, Spigset O. Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms. J Clin Psychopharmacol 2006; 26:192-197.
9. Terao T, Hikichi T. Serotonin syndrome in a case of depression with various somatic symptoms: the difficulty in differential diagnosis. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:295-296.
10. Hansen L, Wilkinson DG. Drug induced akathisia, suicidal ideation and its treatment in the elderly. Int J Geriatr Psychiatry 2001; 16:231-233.
11. Botsaris SD, Sypek JM. Paroxetine and tardive dyskinesia. J Clin Psychopharmacol 1996; 16:258-259.
12. Muthusami S, Basu S, Kumar A, Dash A. Acute dyskinesia and extrapyramidal disorder in a child after ingestion of escitalopram. J Child Adolesc Psychopharmacol 2009; 19:317-318.
13. Erdoǧan S, Çizmeci P, Akçali D, Bolay H. Essitolopram metoklopromid etkileşimi: Bir vaka sunumu. Klinik Psikofarmakoloji Bülteni 2009; 19(Suppl.1):S217-S219.
14. Miletic V, Relja M. Citalopram-induced parkinsonian syndrome: case report. Clin Neuropharmacol 2011; 34:92-93.